# Arcutis Biotherapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2024

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 10-Q/A
- Filed: 2024-07-24
- Accepted by EDGAR: Jul 24, 2024, 16:10 ET
- Period: 2024-03-31
- Accession: 0001193125-24-183778
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000119312524183778/d691902d10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000119312524183778/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000119312524183778/d691902d10qa.htm

Filed Jul 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-183778. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.
